Protocol Design Featured Articles

  1. If Patients Want A Better Quality Of Life, Why Isn't That A Focus For Pharma? 3/25/2025

    Medical oncologist Frédéric Fiteni, Ph.D. reveals the widespread industry reluctance to study patient quality of life, describes its importance to patient satisfaction, and offers best practices for its integration.

  2. Gilead Sees Success With HIV PrEP Trial In South Africa 3/24/2025

    Gilead Sciences' Moupali Das, MD, MPH shares how her team completed the Phase 3 trial for HIV PrEP in South Africa amid challenging conditions.

  3. FAQs On The siRNA Therapeutics 3/21/2025

    Stay ahead in the rapidly evolving field of siRNA therapeutics by exploring the latest clinical trends, breakthrough delivery technologies, combination strategies, and global regulatory pathways.

  4. Insights From A Digital Health Intervention Trial For Heart Failure 3/18/2025

    University of Twente’s Mark Schuuring, MD, Ph.D. explores how digital health tools can successfully support heart failure interventions, despite hesitancy from providers and skepticism about the interest and abilities of a more senior patient population.

  5. Invest In This One Thing To Help Strengthen Your ClinOps Team 3/13/2025

    As clinical research faces unprecedented transformation in trial conduct, sponsor companies that will survive — and thrive — are the ones investing in their people.

  6. Takeda's Diversity Strategy Pays Off For Phase 3 Trial 3/12/2025

    LaShell Robinson, head of global feasibility and trial equity at Takeda explains how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics. 

  7. Social Media And A Site-Less Model Led This Trial To Pandemic-Era Success 3/10/2025

    Genescopy's Chief Science and Medical Officer Erica Barnell, MD, Ph.D. explains how social media recruiting and a site-less trial design helped the company's CRC-PREVENT Phase 3 trial succeed.

  8. Bridging Clinical Research And Care With TransCelerate's Rob DiCicco 3/7/2025

    TransCelerate's Rob DiCicco offers insights into why bridging clinical care and research matters and the challenges that must be overcome to realize the vision.

  9. Lessons Learned From Vivani Medical's Study Of GLP-1 Implant 3/5/2025

    Vivani Medical Cofounder and CEO Adam Mendelsohn, Ph.D. discusses the company’s first application of the NanoPortal, including its upsides for patient adherence, its optimized trial design,  and its reception among sites and patients.

  10. 4 Crucial Differences Between Early-Phase And Late-Phase Trial Site Selection 2/28/2025

    Learn the differences between early-phase and late-phase trial site selection, including what makes an ideal site for early-phase trials, where speed, precision, and adaptability are non-negotiable.